Treventis

From Alzheimers to ALS, Protein Misfolding is a Treatable Pathology

Treventis is paving the way to a future without Alzheimers, Parkinson’s, ALS, Huntington’s disease, and other protein misfolding disorders with their Common Conformational Morphology (CCM) technology. But in order to get the word out, they have to explain what CCM is.

To understand how CCM works, audiences need to understand how proteins are made, how they fold into specific shapes, how they are destroyed within cells, and finally, what can happen when misfolded proteins build up. The fastest and easiest way to get this critical information into the minds of investors and collaborators was to work with Microverse Studios to weave their science into a narrative in the form of a short film.

After receiving the relevant scientific data and a brief overview call, the animators at Microverse Studios did their own research to delve deep into the molecular mechanisms surrounding protein production, folding, and destruction within cells. The animators then built a comprehensive plan for the video and executed it, getting feedback from the team at Treventis at each milestone.

In the end, Treventis had a polished, cinematic quality short film that not only told their story, but
provided a tight brand image as Treventis expanded and moved forward.

CONTACT